This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Balestri, P. Articles by Grosso, S. Search for Related Content PubMed PubMed Citation Articles by Balestri, P. Articles by Grosso, S. Social Bookmarking                   What's this?

Endocrine Disorders in Two Sisters Affected by MELAS Syndrome

Department of Pediatrics University of Siena Siena, Italy, balestri{at}unisi.it

Salvatore Grosso, MD

Department of Pediatrics University of Siena Siena, Italy

A variety of endocrine and metabolic defects, including hypothalamopituitary hypofunction and diabetes mellitus, has been reported in association with mitochondrial disorders. We describe two sisters affected by mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS) syndrome in whom DNA analysis showed an AG transition at the 3243rd nucleotide position on the transfer RNA ^Leu(UUR) gene with 65% and 45% of mutant-type mitochondrial DNA present in the blood cells of the younger and the older sister, respectively. The younger sister had severe involvement of the central nervous system with mental retardation, epilepsia partialis continua, and strokelike episodes. Endocrine investigations showed an extensive neuroendocrine dysfunction with growth hormone deficiency, hypothalamopituitary hypothyroidism, prepubertal gonadotropin levels, and absence of any secondary sexual characteristics at the age of 12 6/12 years. The neurologically normal older sister was affected by diabetes mellitus and had normal hypothalamopituitary function. Our report confirms that the endocrine system can be affected differently by the same mitochondrial DNA mutation, depending on the heteroplasmia phenomenon. A complete endocrine evaluation must be performed in patients affected by mitochondrial disease and the existence of a mitochondrial disorder should be taken into account in patients with endocrine abnormalities, even if neuromuscular signs are lacking. (J Child Neurol 2000;15:755-758).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. Sacconi, L. Salviati, C. Gooch, E. Bonilla, S. Shanske, and S. DiMauro Complex Neurologic Syndrome Associated With the G1606A Mutation of Mitochondrial DNA Arch Neurol, June 1, 2002; 59(6): 1013 - 1015. [Abstract] [Full Text] [PDF]

				S. Grosso, R. Berardi, M. A. Farnetani, M. Margollicci, M. G. Mancini, G. Morgese, and P. Balestri Multiple Neuroendocrine Disorder in Salla Disease J Child Neurol, October 1, 2001; 16(10): 775 - 777. [Abstract] [PDF]